Results 121 to 130 of about 31,086 (166)

Ovarian cancer: the duplicity of CA125 measurement

Nature Reviews Clinical Oncology, 2010
Since it was first described in 1981, CA125 has held an important role in monitoring patients with ovarian cancer. CA125 is elevated in 80% of patients with epithelial ovarian cancer at initial diagnosis and correlates well with response to therapy. CA125 monitoring is used for the follow up of patients with epithelial ovarian cancer, and elevations in
Amer Karam, Karlan Beth Y
exaly   +3 more sources

CA125 and endometriosis

Human Reproduction Update, 1995
This review covers the literature on CA125 and endometriosis; data on CA125 and oncology are not discussed. In normal women, plasma concentrations of CA125 are increased slightly at ovulation and significantly during menstruation. Marked increases are observed during pregnancy and following peritoneal irritation by infection or surgery.
M, Muyldermans   +2 more
openaire   +2 more sources

The prognostic significance of the CA125 nadir in patients that achieve a CA125 response

Journal of Clinical Oncology, 2004
5001 Background:In a series of patients (pts) who had received chemotherapy for epithelial ovarian cancer (EOC) at one hospital, it was observed that survival varied between the groups that attaine...
S. M. Crawford   +5 more
openaire   +1 more source

CA125—A Test with a Change of Heart

Heart, Lung and Circulation, 2011
CA125 is well known as a tumour marker for ovarian cancer. Like all tumour markers it is not specific for a specific tumour and may be elevated in benign disease. Even in ovarian cancer it seems that CA125 is derived from mesothelial production rather than from the cancer cells. CA125 is a natural product of serosal epithelial cells and present in most
openaire   +2 more sources

Effect of Menstruation on Serum CA125 Levels

Asia-Oceania Journal of Obstetrics and Gynaecology, 1992
AbstractCA125 levels were measured in the sera of 54 women with normal menstrual cycle and without infectious, benign and malignant gynecologic disorders. In 54 subjects studied, 13 (24%) had no significant variations in serum CA125 levels throughout the menstrual cycle.
Y Y, Kan, S H, Yeh, H T, Ng, C M, Lou
openaire   +2 more sources

CA125 in Culture Medium of Preimplantation Embryo

Gynecologic and Obstetric Investigation, 2010
The first stage of the implantation is the adhesion of the embryonic pole of the blastocyst to the decidua. Such a phenomenon has been demonstrated to be dependent on the presence of glycoproteic compounds, produced partly by the decidua and partly by the embryo.
Borri P   +7 more
openaire   +3 more sources

Smartphone-based immunosensor for CA125 detection

Talanta, 2017
In this work, we report the design, the development and the characterization of the analytical performances of a colorimetric smartphone-based immunosensor for the detection of cancer antigen 125 (CA125). The immunosensor was based on a sandwich strategy in which the primary antibody was immobilized by spotting onto the 3D nitrocellulose membrane.
HOSU, OANA ALEXANDRA   +5 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy